Saturday, April 19, 2025
22.5 C
Bengaluru

Digital Darwinism or Digital Expert – The Choice for Indian Pharma is Clear

It is heartening to see that Pharma marketers have finally decided to include digital into their marketing mix. Even if catalysed by Covid, this is good news Evan Schwartz called it “digital darwinism” – a phenomenon that caused technology to evolve faster than the society which adopts it. 

The average Indian Pharma marketer has evolved thus:

As technology, its uses and the products that make it relevant to the Pharma business abound, not many have been able to understand it optimally. This made most of us “digitally unaware” or what is less kindly called “illiterates”. These were typically people who thought that digital was just a “wave” or a ‘bubble’ that would eventually burst.

https://www.linkedin.com/pulse/what-would-your-company-look-like-you-built-today-tom-goodwin/

Gartner predicted in 2014 that 75% of all businesses (not just pharma) would eventually become or prepare to become digital businesses by 2020. There is no way, they could have seen Covid catalyse the change, and yet their prediction came true. This eventually means that >90% of customers are already online, since businesses merely follow customers and rarely blaze a new path. The forced shutdown since March helped us realise this in the best possible manner. 

As physical meetings with customers became off-limits, companies were first stumped and then baffled. Soon, realisation dawned that other routes presented opportunities to reach out to them, creating the “digitally aware”. This caused a great deal of floundering to seek out technology. People scrambled to pick tech off the shelves and arm themselves with almost anything that was on offer.

https://blogs.forbes.com/louiscolumbus/files/2019/06/Digital-Business-Means-Becoming-More-Customer-Centric.jpg

In the near future, after a few months of deployment, we might realise that although we are ‘doing digital’, it isn’t as rosy as they had promised it would be! It will probably also clarify two important concepts in our minds – 1) Pushing products isn’t what customers want. And if that isn’t what they want, then what do they want? This Q might make us see the light, that we really don’t know. We always thought we did, but not quite. 

This important step in the evolution of digital transformation is what helps us understand the new ways of working. Ushered in by the new normal, it requires us to fundamentally change the way we operate. This realisation will make us “digital utilitarians” – or people who understand how to use technology to do business in a better way. 

https://www.zs.com/insights/face-to-face-vs-digital-promotion-finding-the-right-balance

We will then realise that the changed ways of working are less about doing the same thing via a new medium, and more about doing what the customer wants. Customer behaviours change quite a bit when they move online. The impersonal medium reduces personal relationships, the obligations that come with them, and sometimes induces rude or irrational behaviour. Dealing with online media to manage relationships is a very different ball game. 

https://medicinman.net/2018/10/digistorm-2018-intent-content-strategy-and-skills/

We reach a stage of “digital experts” when we realise that our:

Intent is to serve customers at scale through an outside-in view

Content is to use the context that comes from customer insights, develop relevant content and use the right channels (context -> content -> channel)

Strategy is to bring the voice of the customer into the organisation and co-create value through data, journeys and maps

Skills is to ensure that the commercial teams obsess over customers, develop the skills (and not depend on a ‘digital team’), own the outreach and wrap it around their brand strategies. 

Here is to hoping that Indian pharma is soon full of digital experts who have their intent honed well, content aligned with customer context, constantly upgrading skills and thinking of how their strategy  can serve at scale. 

Digital Excellence Pharma Academy – DEPA 2.0 – Case Study Based Workshop for Pharma People

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img